Archive for March 2021

EP Solutions SA is the sponsor of the MAP-CRT multicentre clinical trial. This study is designed to assess whether an ECGi measurement with Amycard 01C can be used to predict the outcome of cardiac resynchronization therapy. Despite the added difficulties due to the covid-19 pandemic, five sites are live: Hospital da Luz in Lisbon, Petrovsky…

Read More